Riskpilot← Back to searchSign inGet full accessK Halldin Läkarkonsult AB
ABActiveOrg 5566445408Kråkeskärsgatan 4Hospital activities · NACE 8610Est. 20031 employees
Revenue 2024
SEK 2,2M
-25% vs 2023
EBITDA margin
7.5%
-79% vs 2023
Equity ratio
93.9%
Financial strength
Net profit 2024
SEK 939K
-98% vs 2023
| Revenue | SEK 2,2M | -25% |
| EBITDA | SEK 164K | -79% |
| Net profit | SEK 939K | -98% |
| Total assets | SEK 59,3M | -2% |
| Equity | SEK 55,7M | +1% |
| Employees | 1 | — |
Legal name
K Halldin Läkarkonsult AB
Org number
5566445408
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
25 juni 2003
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva verksamhet inom sjukvård, friskvård, hälsovård samt därmed förenlig verksamhet och bedriva handel med aktier, obligationer, andra värdepapper samt fast egendom, uthyrning av fast egendom samt därmed förenlig verksamhet.
Address
Kråkeskärsgatan 4
Phone
+4631470026
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 445 | 2 260 | 2 536 | 2 935 | 2 187 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 438 | 830 | 1 123 | 768 | 164 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 438 | 830 | 1 123 | 768 | 164 |
| Net financials | −2 887 | 958 | −1 444 | 43 074 | 640 |
| Profit before tax | 387 | 1 783 | 649 | 43 902 | 1 197 |
| Tax | −387 | −308 | −290 | −305 | −258 |
| Net profit | 0 | 1 475 | 359 | 43 597 | 939 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 15 990 | 16 399 | 16 750 | 60 276 | 59 342 |
| Equity | 10 940 | 12 232 | 12 404 | 55 431 | 55 736 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 621 | 734 | 930 | 1 488 | 979 |
| Total debt | 1 621 | 734 | 930 | 1 488 | 979 |
EBITDA margin
7.5%
This company
15.8%
Market median
-53% vs market
20202024
Equity ratio
93.9%
This company
38.2%
Market median
+146% vs market
20202024
Return on equity
1.7%
This company
18.4%
Market median
-91% vs market
20202024
Net profit margin
42.9%
This company
8.1%
Market median
+430% vs market
20202024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20202024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KM Chief Executive Officer | Chief Executive Officer | 2021 |
UH Audit | Audit | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
K Halldin Läkarkonsult AB 
Önnereds Hälso- & PR-Byrå ABBoard members of K Halldin Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Klas Mattias Halldin Lindorsson | Chief Executive Officer | 0 companies |
| Ulf Henrik Lundin | Audit | 0 companies |
| Anders Mikael Gillis Johansson | Deputy Board Member | 0 companies |